David Nierengarten

Stock Analyst at Wedbush

(3.75)
# 757
Out of 4,984 analysts
203
Total ratings
46.63%
Success rate
9.16%
Average return

Stocks Rated by David Nierengarten

Nuvation Bio
Sep 8, 2025
Reiterates: Outperform
Price Target: $6
Current: $3.27
Upside: +83.49%
Nuvalent
Sep 8, 2025
Reiterates: Outperform
Price Target: $115
Current: $78.33
Upside: +46.81%
Shattuck Labs
Sep 8, 2025
Initiates: Outperform
Price Target: $4
Current: $2.14
Upside: +86.92%
Xencor
Sep 2, 2025
Reiterates: Outperform
Price Target: $26
Current: $8.62
Upside: +201.62%
Telix Pharmaceuticals
Aug 28, 2025
Reiterates: Outperform
Price Target: $22
Current: $9.42
Upside: +133.55%
BridgeBio Oncology Therapeutics
Aug 18, 2025
Initiates: Outperform
Price Target: $25
Current: $9.99
Upside: +150.25%
Generation Bio Co.
Aug 13, 2025
Downgrades: Neutral
Price Target: $7
Current: $5.95
Upside: +17.65%
Vor Biopharma
Jun 26, 2025
Reiterates: Neutral
Price Target: $0.4
Current: $1.57
Upside: -74.52%
argenx SE
Jun 24, 2025
Reiterates: Outperform
Price Target: $715
Current: $752.32
Upside: -4.96%
Perspective Therapeutics
Jun 23, 2025
Reiterates: Outperform
Price Target: $11
Current: $3.27
Upside: +236.39%
Reiterates: Neutral
Price Target: $10
Current: $12.27
Upside: -18.50%
Maintains: Neutral
Price Target: $29$27
Current: $12.68
Upside: +112.93%
Reiterates: Outperform
Price Target: $34
Current: $35.77
Upside: -4.95%
Reiterates: Outperform
Price Target: $33
Current: $9.09
Upside: +263.04%
Downgrades: Neutral
Price Target: $8$2
Current: $0.89
Upside: +124.32%
Reiterates: Neutral
Price Target: $5
Current: $0.95
Upside: +425.93%
Reiterates: Outperform
Price Target: $31
Current: $11.25
Upside: +175.56%
Maintains: Outperform
Price Target: $40
Current: $19.39
Upside: +106.29%
Maintains: Outperform
Price Target: $87$90
Current: $36.84
Upside: +144.30%
Maintains: Outperform
Price Target: $40$47
Current: $32.34
Upside: +45.33%
Reiterates: Outperform
Price Target: $23
Current: $8.61
Upside: +167.13%
Reiterates: Outperform
Price Target: $20
Current: $10.90
Upside: +83.49%
Initiates: Outperform
Price Target: $40
Current: $14.90
Upside: +168.46%
Initiates: Outperform
Price Target: $45
Current: $14.82
Upside: +203.64%
Reiterates: Outperform
Price Target: $10
Current: $1.72
Upside: +481.40%
Initiates: Outperform
Price Target: $18
Current: $2.37
Upside: +659.49%
Reiterates: Outperform
Price Target: $57
Current: $60.34
Upside: -5.54%
Reiterates: Neutral
Price Target: $10
Current: $12.54
Upside: -20.26%
Reiterates: Outperform
Price Target: $12
Current: $4.67
Upside: +156.96%
Reiterates: Outperform
Price Target: $57
Current: $22.91
Upside: +148.80%
Upgrades: Outperform
Price Target: $50$175
Current: $7.21
Upside: +2,327.18%
Maintains: Equal-Weight
Price Target: $1,400$500
Current: $3.95
Upside: +12,558.23%
Maintains: Neutral
Price Target: $105$60
Current: $6.26
Upside: +858.47%
Maintains: Outperform
Price Target: $11$19
Current: $8.85
Upside: +114.69%
Maintains: Outperform
Price Target: $71$75
Current: $29.48
Upside: +154.41%
Downgrades: Neutral
Price Target: n/a
Current: $1.15
Upside: -
Upgrades: Outperform
Price Target: n/a
Current: $4.25
Upside: -
Downgrades: Neutral
Price Target: n/a
Current: $8.16
Upside: -